Alcolase is a Danish biotech company developing enzyme-based technology for alcohol intolerance.

Ardos is a Danish MedTech company developing vendor-agnostic software for real-time dose reconstruction in radiotherapy.

EtOH is a Danish foodtech company developing technology to accelerate and optimise the maturation of spirits.

LaevaCare is a Danish MedTech company developing a physical support device designed to relieve and support the pelvic floor after vaginal childbirth.

The page describes Delphinus Venture Capital’s approach: founders have 30 minutes to demonstrate problem-solving skills and team capability.

Turning great Danish research into global success takes the right people, ambition, risk appetite and faster decisions.

Urologist Jacob Elmose founded Cystotech to address diagnostic uncertainty in bladder cancer after years in clinical practice.

While Europe fears falling behind in the global AI race, a Denmark-based company stands as one of the most promising candidates for the next wave of technology: real-world AI. These are models that understand climate, energy, and the physical infrastructure upon which society is built.

The fund, founded by Aarhus Universitets Forskningsfond, HEARTLAND, Norlys, and Salling Group, is based in INCUBA to engage with East Jutland’s innovation ecosystem.

The four partners established Delphinus Venture Capital to foster growth in East and Central Jutland’s startup ecosystem, especially research-driven ventures.

Delphinus Venture Capital, a new Danish venture fund based in Aarhus, invests in research-driven startups and scaleups.

30. October 2025 / 17. December 2025 by grobowski

2. July 2026 / 29. July 2026 by Katrine Riisberg

6. October 2026 / 6. October 2026 by Rasmus Sørensen

The page describes a professional background in strategy, communications, and partnerships, including leadership at Danish Industry.

Delphinus Venture Capital backs early-stage founders and supports them through Series B, acting as an evergreen fund.

The fund emphasizes transparency in investment and collaboration, sharing insights openly with founders.

Danish industrial biotech company NorFalk secures funding to commercialize its bio-based alternatives. Its initial products already outperform conventional options derived from petrochemicals, palm oil, or palm kernel oil. The company targets replacing fossil-based chemistry in everyday consumer goods.

Aug 2026Delphinus Venture CapitalNews article

Oktogrid, a Danish startup, secures **EUR 4 million** in funding to develop **acoustic monitoring solutions** for power transformers. The company uses sensor-based technology to analyze transformer health and provide real-time insights for electrical infrastructure. Founded in 2019 by **Golam Sadeghnia**, Oktogrid targets an underserved segment of grid management by focusing on predictive maintenance for transformers.

Jul 2026Delphinus Venture CapitalNews article

Alcolase, a Danish biotech startup, develops solutions to address alcohol intolerance, a condition impacting **540 million people worldwide**. Founded by Mikkel Precht and co-founders, the company leverages biotechnology to address this understudied health issue. The initiative originated from discussions during the coronavirus pandemic, where the team identified alcohol intolerance as a critical but overlooked global health challenge.

May 2026Delphinus Venture CapitalNews article

Ardos develops technology that enables real-time verification of radiation doses delivered during cancer treatment. Clinicians previously lacked certainty about the actual dose patients received, despite optimized treatment planning. The company’s solution aims to address this gap in radiotherapy precision.

May 2026Delphinus Venture CapitalNews article